nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An apparent clinical pharmacokinetic drug–drug interaction between bevacizumab and the anti-placental growth factor monoclonal antibody RO5323441 via a target-trapping mechanism
|
Wang, Ka |
|
2017 |
79 |
4 |
p. 661-671 |
artikel |
2 |
A phase II study of REOLYSIN® (pelareorep) in combination with carboplatin and paclitaxel for patients with advanced malignant melanoma
|
Mahalingam, Devalingam |
|
2017 |
79 |
4 |
p. 697-703 |
artikel |
3 |
A phase II study of REOLYSIN® (pelareorep) in combination with carboplatin and paclitaxel for patients with advanced malignant melanoma
|
Mahalingam, Devalingam |
|
|
79 |
4 |
p. 697-703 |
artikel |
4 |
A phase 1 study of anti-TGFβ receptor type-II monoclonal antibody LY3022859 in patients with advanced solid tumors
|
Tolcher, Anthony W. |
|
2017 |
79 |
4 |
p. 673-680 |
artikel |
5 |
A phase 1 study of gemcitabine/nab-paclitaxel/S-1 (GAS) combination neoadjuvant chemotherapy for patients with locally advanced pancreatic adenocarcinoma
|
Kondo, Naru |
|
2017 |
79 |
4 |
p. 775-781 |
artikel |
6 |
Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia
|
Galeotti, Laura |
|
2017 |
79 |
4 |
p. 767-773 |
artikel |
7 |
Cooperative inhibitory effects of uremic toxins and other serum components on OATP1B1-mediated transport of SN-38
|
Katsube, Yurie |
|
2017 |
79 |
4 |
p. 783-789 |
artikel |
8 |
Correlation between clinical response to sorafenib in hepatocellular carcinoma treatment and polymorphisms of P-glycoprotein (ABCB1) and of breast cancer resistance protein (ABCG2): monocentric study
|
Tandia, Mahamadou |
|
2017 |
79 |
4 |
p. 759-766 |
artikel |
9 |
hOCT1 gene expression predict for optimal response to Imatinib in Tunisian patients with chronic myeloid leukemia
|
Ben Hassine, Islem |
|
2017 |
79 |
4 |
p. 737-745 |
artikel |
10 |
Inhibition of GOT1 sensitizes colorectal cancer cells to 5-fluorouracil
|
Hong, Chengyu |
|
2017 |
79 |
4 |
p. 835-840 |
artikel |
11 |
In vitro and in vivo evaluation of dasatinib and imatinib on physiological parameters of pulmonary arterial hypertension
|
Baumgart, Bethany |
|
2017 |
79 |
4 |
p. 711-723 |
artikel |
12 |
Multicenter, randomized, open-label Phase II study comparing S-1 alternate-day oral therapy with the standard daily regimen as a first-line treatment in patients with unresectable advanced pancreatic cancer
|
Yamaue, Hiroki |
|
2017 |
79 |
4 |
p. 813-823 |
artikel |
13 |
Outcome in advanced non-small cell lung cancer patients with successful rechallenge after recovery from epidermal growth factor receptor tyrosine kinase inhibitor-induced interstitial lung disease
|
Kashiwabara, Kosuke |
|
2017 |
79 |
4 |
p. 705-710 |
artikel |
14 |
Pemetrexed monotherapy for chemo-naïve elderly (aged ≥80) patients with non-squamous non-small cell lung cancer: results from combined analysis of two single arm phase II studies (HANSHIN002 and 003)
|
Hata, Akito |
|
2017 |
79 |
4 |
p. 689-695 |
artikel |
15 |
Phase 1b study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced melanoma (KEYNOTE-041)
|
Yamazaki, Naoya |
|
2017 |
79 |
4 |
p. 651-660 |
artikel |
16 |
Phase I single dose, two-period and two-sequence cross-over trial to evaluate the relative bioavailability of two oral pimasertib formulations in advanced cancer patients
|
Mahadevan, D. |
|
2017 |
79 |
4 |
p. 681-688 |
artikel |
17 |
Polymeric micelles as mighty nanocarriers for cancer gene therapy: a review
|
Yousefpour Marzbali, Mahsa |
|
2017 |
79 |
4 |
p. 637-649 |
artikel |
18 |
Prognostic impact of normalization of serum tumor markers following neoadjuvant chemotherapy in patients with borderline resectable pancreatic carcinoma with arterial contact
|
Murakami, Yoshiaki |
|
2017 |
79 |
4 |
p. 801-811 |
artikel |
19 |
Reply: Methotrexate neurotoxicity due to drug interactions: an inadequate folinic acid effect
|
Forster, Victoria J. |
|
2017 |
79 |
4 |
p. 841-842 |
artikel |
20 |
Synthesis of short retinoidal amides related to fenretinide: antioxidant activities and differentiation-inducing ability
|
Anzaldi, Maria |
|
2017 |
79 |
4 |
p. 725-736 |
artikel |
21 |
The influence of TNF-α and Ang II on the proliferation, migration and invasion of HepG2 cells by regulating the expression of GRK2
|
Xu, Zhou-wei |
|
2017 |
79 |
4 |
p. 747-758 |
artikel |
22 |
The role of circulating tumor cells in evaluation of prognosis and treatment response in advanced non-small-cell lung cancer
|
Zhou, Jia |
|
2017 |
79 |
4 |
p. 825-833 |
artikel |
23 |
XPG genetic polymorphisms and clinical outcome of patients with advanced non-small cell lung cancer under platinum-based treatment: a meta-analysis of 12 studies
|
Xiang, Tianxin |
|
2017 |
79 |
4 |
p. 791-800 |
artikel |